Professor Bernardo Leon Rapoport
M.Med. (Witwatersrand) Extraordinary Professor, Department of Immunology, Faculty of Health Science, University of Pretoria, South Africa.
Professor Rapoport is an Extraordinary Professor in the Department of Immunology, Faculty of Health Science, University of Pretoria and Medical Oncologist in private practice in Johannesburg. He has been in private practice at The Medical Oncology Centre of Rosebank since 1993.
After earning his medical degree in 1978 from the University of Buenos Aires in Argentina, he completed an internship at Tel Aviv University in Israel. Prof. Rapoport then specialized in Internal Medicine at the University of the Witwatersrand in Johannesburg, South Africa following which he served as a fellow in Medical Oncology at the University of Pretoria, where he became certified as a Medical Oncologist and subsequently worked as a Senior Consultant and Senior Lecturer until 1993.
Professor Rapoport is the current Chairman of the South African Society of Medical Oncology (SASMO), and serves on the Board of Directors of the Multinational Association of Supportive Care in Cancer (MASCC). He is also the co-chairman of the MASCC Antiemetic and Neutropenia, Infection and Myelosuppression Study Group.
Professor Rapoport is an examiner for the Medical Oncology Certification for the College of Medicine of South Africa. He is a former examiner for the M. Med. Clinical Oncology postgraduate examinations at the University of Natal.
Professor Rapoport’s research efforts have focused on cancer supportive care, mainly febrile neutropenia and chemotherapy induced nausea and vomiting (CINV), breast cancer, lung cancer, melanoma ad more recently immuno-oncology. His clinical practice focuses on both solid tumours and haematological malignancies.
In recent years Professor Rapoport has been involved in numerous pivotal trials of several groundbreaking therapies to treat various solid tumors, febrile neutropenia and CINV. As frequently invited speaker, Professor Rapoport has delivered more than a 200 lectures at local, regional and international conferences and symposia including ASCO, ESMO, MASCC and SASMO.
He is also a reviewer for several high impact scientific journals such as Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology and Journal of Supportive Care in Cancer (JSCC). Professor Rapoport is currently a member of the editorial boards of various scientific journals such as ESMO Open and JSCC. He is also been lead guess editor for Frontiers in Pharmacology, and Frontiers in Immunology.
He has authored and co-authored various book chapters and has published more than 100 scientific papers in peer reviewed journals including Lancet Oncology, Journal of Clinical Oncology, Annals of Oncology, Journal of Global Oncology, Cancer and Journal of Supportive Care in Cancer. Professor Rapoport is a member of local, regional and international Advisory Boards of several multinational pharmaceutical companies. He is also a frequently invited expert speaker in his field by pharmaceutical companies at a local, regional and international level. Professor Rapoport also lectures for the European School of Oncology (ESO).
Professor Rapoport serves as a member of the MASCC/ESMO Antiemetic Guidelines Working Group, as well as the ESMO Febrile Neutropenia and G-CSF Guidelines Committees. He is also involved in the MASCC guidelines for the management of immune-related adverse events of checkpoint inhibitor treatment.
Professor Rapoport has for the past 6 years, been a member of the Scientific Committee for the MASCC/ISOO annual meeting, and for ESMO Africa and ESMO annual congresses for 2016 and 2017.